WOCKPHARMA.NS Balance Sheet
Wockhardt Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 01:46
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹20.22 Bn | ₹18.75 Bn | ₹17.18 Bn | ₹16.18 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹4.14 Bn | ₹4.34 Bn | ₹5.13 Bn | ₹6.71 Bn | CapitalWorkInProgress |
| Goodwill | ₹9.45 Bn | ₹9.53 Bn | ₹9.77 Bn | ₹10.28 Bn | Goodwill |
| Other Intangible Assets | ₹0.75 Bn | ₹0.53 Bn | ₹0.41 Bn | ₹1.45 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹2.22 Bn | ₹2.18 Bn | ₹1.95 Bn | ₹1.99 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹54.75 Bn | ₹54.65 Bn | ₹55.66 Bn | ₹59.18 Bn | NoncurrentAssets |
| Inventories | ₹6.58 Bn | ₹6.40 Bn | ₹7.25 Bn | ₹8.87 Bn | Inventories |
| Trade Receivables | ₹7.97 Bn | ₹6.18 Bn | ₹6.61 Bn | ₹5.88 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹0.90 Bn | ₹5.05 Bn | ₹1.12 Bn | ₹2.17 Bn | CashAndCashEquivalents |
| Current Investments | ₹0.00 Bn | ₹0.00 Bn | ₹4.22 Bn | ₹4.12 Bn | CurrentInvestments |
| Other Current Assets | ₹3.09 Bn | ₹2.68 Bn | ₹4.12 Bn | ₹4.18 Bn | OtherCurrentAssets |
| Total Current Assets | ₹19.14 Bn | ₹20.73 Bn | ₹24.65 Bn | ₹26.06 Bn | CurrentAssets |
| Total Assets | ₹76.83 Bn | ₹76.49 Bn | ₹81.35 Bn | ₹86.15 Bn | Assets |
| Equity Share Capital | ₹0.72 Bn | ₹0.77 Bn | ₹0.81 Bn | ₹0.81 Bn | EquityShareCapital |
| Other Equity | ₹32.82 Bn | ₹32.82 Bn | ₹42.72 Bn | ₹48.59 Bn | OtherEquity |
| Equity Attributable to Owners | ₹33.54 Bn | ₹33.59 Bn | ₹43.53 Bn | ₹49.40 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹3.08 Bn | ₹3.03 Bn | ₹3.04 Bn | ₹3.41 Bn | NonControllingInterest |
| Total Equity | ₹36.62 Bn | ₹36.62 Bn | ₹46.57 Bn | ₹52.81 Bn | Equity |
| Long-term Borrowings | ₹2.24 Bn | ₹8.91 Bn | ₹12.11 Bn | ₹15.18 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹5.86 Bn | ₹11.96 Bn | ₹14.36 Bn | ₹17.12 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹16.63 Bn | ₹12.21 Bn | ₹6.48 Bn | ₹6.07 Bn | BorrowingsCurrent |
| Trade Payables | ₹8.67 Bn | ₹7.66 Bn | ₹5.92 Bn | ₹5.63 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹1.26 Bn | ₹1.63 Bn | ₹2.38 Bn | ₹2.03 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹34.35 Bn | ₹27.91 Bn | ₹20.42 Bn | ₹16.22 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹76.83 Bn | ₹76.49 Bn | ₹81.35 Bn | ₹86.15 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from WOCKPHARMA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).